Literature DB >> 32851637

Protein phase separation: A novel therapy for cancer?

Wei Wang1, Yingqian Chen1, Aixiao Xu1, Minyi Cai1, Ji Cao1, Hong Zhu1, Bo Yang1, Xuejing Shao1, Meidan Ying1, Qiaojun He1.   

Abstract

In recent years, phase separation has been increasingly reported to play a pivotal role in a wide range of biological processes. Due to the close relationships between cancer and disorders in intracellular physiological function, the identification of new mechanisms involved in intracellular regulation has been regarded as a new direction for cancer therapy. Introducing the concept of phase separation into complex descriptions of disease mechanisms may provide many different insights. Here, we review the recent findings on the phase separation of cancer-related proteins, describing the possible relationships between phase separation and key proteins associated with cancer and indicate possible regulatory modalities, especially drug candidates for phase separation, which may provide more effective strategies for cancer therapy.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  drug candidate; epigenetics; phase separation; protein degradation; signal transduction; transcription; translation

Mesh:

Substances:

Year:  2020        PMID: 32851637      PMCID: PMC7589017          DOI: 10.1111/bph.15242

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  161 in total

1.  mTOR Regulates Phase Separation of PGL Granules to Modulate Their Autophagic Degradation.

Authors:  Gangming Zhang; Zheng Wang; Zhuo Du; Hong Zhang
Journal:  Cell       Date:  2018-08-30       Impact factor: 41.582

Review 2.  Fuzziness in Protein Interactions-A Historical Perspective.

Authors:  Monika Fuxreiter
Journal:  J Mol Biol       Date:  2018-02-23       Impact factor: 5.469

Review 3.  Assembly of Mitotic Structures through Phase Separation.

Authors:  Jeffrey B Woodruff
Journal:  J Mol Biol       Date:  2018-05-08       Impact factor: 5.469

Review 4.  Matter over mind: Liquid phase separation and neurodegeneration.

Authors:  Shana Elbaum-Garfinkle
Journal:  J Biol Chem       Date:  2019-03-26       Impact factor: 5.157

Review 5.  TPX2: of spindle assembly, DNA damage response, and cancer.

Authors:  Gernot Neumayer; Camille Belzil; Oliver J Gruss; Minh Dang Nguyen
Journal:  Cell Mol Life Sci       Date:  2014-02-21       Impact factor: 9.261

Review 6.  The Structure and Dynamics of Higher-Order Assemblies: Amyloids, Signalosomes, and Granules.

Authors:  Hao Wu; Monika Fuxreiter
Journal:  Cell       Date:  2016-05-19       Impact factor: 41.582

7.  Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA.

Authors:  Z Zou; B Huang; X Wu; H Zhang; J Qi; J Bradner; S Nair; L-F Chen
Journal:  Oncogene       Date:  2013-05-20       Impact factor: 9.867

8.  DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.

Authors:  J Bartkova; Z Horejsí; M Sehested; J M Nesland; E Rajpert-De Meyts; N E Skakkebaek; M Stucki; S Jackson; J Lukas; J Bartek
Journal:  Oncogene       Date:  2007-06-04       Impact factor: 9.867

9.  The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.

Authors:  Rossella Lucá; Michele Averna; Francesca Zalfa; Manuela Vecchi; Fabrizio Bianchi; Giorgio La Fata; Franca Del Nonno; Roberta Nardacci; Marco Bianchi; Paolo Nuciforo; Sebastian Munck; Paola Parrella; Rute Moura; Emanuela Signori; Robert Alston; Anna Kuchnio; Maria Giulia Farace; Vito Michele Fazio; Mauro Piacentini; Bart De Strooper; Tilmann Achsel; Giovanni Neri; Patrick Neven; D Gareth Evans; Peter Carmeliet; Massimiliano Mazzone; Claudia Bagni
Journal:  EMBO Mol Med       Date:  2013-09-16       Impact factor: 12.137

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets.

Authors:  Stephen P H Alexander; Eamonn Kelly; Alistair Mathie; John A Peters; Emma L Veale; Jane F Armstrong; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; O Peter Buneman; John A Cidlowski; Arthur Christopoulos; Anthony P Davenport; Doriano Fabbro; Michael Spedding; Jörg Striessnig; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2019-12       Impact factor: 8.739

View more
  5 in total

Review 1.  Protein phase separation: A novel therapy for cancer?

Authors:  Wei Wang; Yingqian Chen; Aixiao Xu; Minyi Cai; Ji Cao; Hong Zhu; Bo Yang; Xuejing Shao; Meidan Ying; Qiaojun He
Journal:  Br J Pharmacol       Date:  2020-09-28       Impact factor: 8.739

2.  The Regulatory Roles of Intrinsically Disordered Linker in VRN1-DNA Phase Separation.

Authors:  Qiaojing Huang; Yanyan Wang; Zhirong Liu; Luhua Lai
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 3.  Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.

Authors:  Doris Loh; Russel J Reiter
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

Review 4.  3D chromatin architecture and transcription regulation in cancer.

Authors:  Siwei Deng; Yuliang Feng; Siim Pauklin
Journal:  J Hematol Oncol       Date:  2022-05-04       Impact factor: 23.168

5.  Tension of plus-end tracking protein Clip170 confers directionality and aggressiveness during breast cancer migration.

Authors:  Yunfeng Hu; Qiu Xie; Xiang Wu; Weizhen Liu; DongFang Li; Chen Li; WangXing Zhao; LinLin Chen; Zihui Zheng; GuangMing Li; Jun Guo
Journal:  Cell Death Dis       Date:  2022-10-08       Impact factor: 9.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.